Epigenomics to Meet with FDA, Hire US Head as it Looks to Crack US Market

The German firm is adapting its Epi proColon test to meet FDA requirements and hopes to commercialize it in the US in the second half of 2012.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.